(SNX) Synnex - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US87162W1009
Stock: Technology Distribution, Cloud Services, IT Solutions, Logistics Support
Total Rating 46
Risk 78
Buy Signal -0.44
| Risk 5d forecast | |
|---|---|
| Volatility | 29.7% |
| Relative Tail Risk | -9.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.66 |
| Alpha | -0.67 |
| Character TTM | |
|---|---|
| Beta | 1.255 |
| Beta Downside | 0.559 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.78% |
| CAGR/Max DD | 0.64 |
EPS (Earnings per Share)
Revenue
Description: SNX Synnex March 06, 2026
TD SYNNEX Corporation (SNX) is an IT distributor and solutions aggregator. The company provides a wide range of technology products and services, serving various reseller types globally.
Its offerings include endpoint solutions like personal computing devices and mobile phones, and advanced solutions such as hybrid cloud and cybersecurity. Technology distributors like SNX play a critical role in the IT supply chain, connecting hardware and software vendors with a broad network of resellers and end-users.
TD SYNNEX also provides value-added services, including design, integration, logistics, and financial solutions like leasing and device-as-a-service. Value-added services are a key differentiator in the competitive IT distribution sector, allowing companies to offer more comprehensive solutions beyond just product delivery.
To deepen your understanding of SNXs market position and financial health, consider exploring its detailed performance metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 827.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.61 > 1.0 |
| NWC/Revenue: 6.92% < 20% (prev 7.02%; Δ -0.10% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.53b > Net Income 827.7m |
| Net Debt (2.18b) to EBITDA (1.83b): 1.19 < 3 |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (80.9m) vs 12m ago -4.24% < -2% |
| Gross Margin: 6.50% > 18% (prev 0.06%; Δ 643.7% > 0.5%) |
| Asset Turnover: 193.7% > 50% (prev 193.1%; Δ 0.67% > 0%) |
| Interest Coverage Ratio: 3.96 > 6 (EBITDA TTM 1.83b / Interest Expense TTM 356.6m) |
Altman Z'' 1.58
| A: 0.13 (Total Current Assets 25.29b - Total Current Liabilities 20.96b) / Total Assets 34.25b |
| B: 0.10 (Retained Earnings 3.44b / Total Assets 34.25b) |
| C: 0.04 (EBIT TTM 1.41b / Avg Total Assets 32.26b) |
| D: 0.12 (Book Value of Equity 3.06b / Total Liabilities 25.80b) |
| Altman-Z'' Score: 1.58 = BB |
Beneish M -3.09
| DSRI: 1.05 (Receivables 12.68b/11.30b, Revenue 62.51b/58.45b) |
| GMI: 0.93 (GM 6.50% / 6.05%) |
| AQI: 0.88 (AQ_t 0.25 / AQ_t-1 0.28) |
| SGI: 1.07 (Revenue 62.51b / 58.45b) |
| TATA: -0.02 (NI 827.7m - CFO 1.53b) / TA 34.25b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of SNX shares?
As of March 07, 2026, the stock is trading at USD 156.37 with a total of 596,906 shares traded.
Over the past week, the price has changed by -0.28%, over one month by -8.76%, over three months by +1.69% and over the past year by +22.56%.
Over the past week, the price has changed by -0.28%, over one month by -8.76%, over three months by +1.69% and over the past year by +22.56%.
Is SNX a buy, sell or hold?
Synnex has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy SNX.
- StrongBuy: 5
- Buy: 5
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SNX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 179.7 | 14.9% |
| Analysts Target Price | 179.7 | 14.9% |
SNX Fundamental Data Overview March 05, 2026
P/E Trailing = 15.6955
P/E Forward = 11.0254
P/S = 0.2017
P/B = 1.4994
P/EG = 1.0018
Revenue TTM = 62.51b USD
EBIT TTM = 1.41b USD
EBITDA TTM = 1.83b USD
Long Term Debt = 3.59b USD (from longTermDebt, last quarter)
Short Term Debt = 1.02b USD (from shortTermDebt, last quarter)
Debt = 4.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.18b USD (from netDebt column, last quarter)
Enterprise Value = 14.78b USD (12.61b + Debt 4.61b - CCE 2.44b)
Interest Coverage Ratio = 3.96 (Ebit TTM 1.41b / Interest Expense TTM 356.6m)
EV/FCF = 10.64x (Enterprise Value 14.78b / FCF TTM 1.39b)
FCF Yield = 9.40% (FCF TTM 1.39b / Enterprise Value 14.78b)
FCF Margin = 2.22% (FCF TTM 1.39b / Revenue TTM 62.51b)
Net Margin = 1.32% (Net Income TTM 827.7m / Revenue TTM 62.51b)
Gross Margin = 6.50% ((Revenue TTM 62.51b - Cost of Revenue TTM 58.45b) / Revenue TTM)
Gross Margin QoQ = 6.44% (prev 6.73%)
Tobins Q-Ratio = 0.43 (Enterprise Value 14.78b / Total Assets 34.25b)
Interest Expense / Debt = 1.79% (Interest Expense 82.5m / Debt 4.61b)
Taxrate = 20.13% (62.6m / 311.0m)
NOPAT = 1.13b (EBIT 1.41b * (1 - 20.13%))
Current Ratio = 1.21 (Total Current Assets 25.29b / Total Current Liabilities 20.96b)
Debt / Equity = 0.55 (Debt 4.61b / totalStockholderEquity, last quarter 8.45b)
Debt / EBITDA = 1.19 (Net Debt 2.18b / EBITDA 1.83b)
Debt / FCF = 1.57 (Net Debt 2.18b / FCF TTM 1.39b)
Total Stockholder Equity = 8.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.57% (Net Income 827.7m / Total Assets 34.25b)
RoE = 9.94% (Net Income TTM 827.7m / Total Stockholder Equity 8.32b)
RoCE = 11.86% (EBIT 1.41b / Capital Employed (Equity 8.32b + L.T.Debt 3.59b))
RoIC = 8.93% (NOPAT 1.13b / Invested Capital 12.64b)
WACC = 8.10% (E(12.61b)/V(17.22b) * Re(10.54%) + D(4.61b)/V(17.22b) * Rd(1.79%) * (1-Tc(0.20)))
Discount Rate = 10.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.37%
[DCF] Terminal Value 73.90% ; FCFF base≈1.25b ; Y1≈998.3m ; Y5≈673.5m
[DCF] Fair Price = 124.5 (EV 12.22b - Net Debt 2.18b = Equity 10.04b / Shares 80.6m; r=8.10% [WACC]; 5y FCF grow -24.13% → 2.90% )
EPS Correlation: 43.51 | EPS CAGR: 6.45% | SUE: 0.57 | # QB: 0
Revenue Correlation: 14.27 | Revenue CAGR: 3.15% | SUE: 0.99 | # QB: 3
EPS next Quarter (2026-05-31): EPS=3.42 | Chg7d=+0.001 | Chg30d=+0.006 | Revisions Net=+2 | Analysts=11
EPS current Year (2026-11-30): EPS=14.62 | Chg7d=-0.014 | Chg30d=-0.023 | Revisions Net=-2 | Growth EPS=+10.8% | Growth Revenue=+3.9%
EPS next Year (2027-11-30): EPS=16.09 | Chg7d=-0.022 | Chg30d=-0.026 | Revisions Net=-2 | Growth EPS=+10.1% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.2% (Discount Rate 10.5% - Earnings Yield 6.4%)
[Growth] Growth Spread = +1.5% (Analyst 5.7% - Implied 4.2%)
P/E Forward = 11.0254
P/S = 0.2017
P/B = 1.4994
P/EG = 1.0018
Revenue TTM = 62.51b USD
EBIT TTM = 1.41b USD
EBITDA TTM = 1.83b USD
Long Term Debt = 3.59b USD (from longTermDebt, last quarter)
Short Term Debt = 1.02b USD (from shortTermDebt, last quarter)
Debt = 4.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.18b USD (from netDebt column, last quarter)
Enterprise Value = 14.78b USD (12.61b + Debt 4.61b - CCE 2.44b)
Interest Coverage Ratio = 3.96 (Ebit TTM 1.41b / Interest Expense TTM 356.6m)
EV/FCF = 10.64x (Enterprise Value 14.78b / FCF TTM 1.39b)
FCF Yield = 9.40% (FCF TTM 1.39b / Enterprise Value 14.78b)
FCF Margin = 2.22% (FCF TTM 1.39b / Revenue TTM 62.51b)
Net Margin = 1.32% (Net Income TTM 827.7m / Revenue TTM 62.51b)
Gross Margin = 6.50% ((Revenue TTM 62.51b - Cost of Revenue TTM 58.45b) / Revenue TTM)
Gross Margin QoQ = 6.44% (prev 6.73%)
Tobins Q-Ratio = 0.43 (Enterprise Value 14.78b / Total Assets 34.25b)
Interest Expense / Debt = 1.79% (Interest Expense 82.5m / Debt 4.61b)
Taxrate = 20.13% (62.6m / 311.0m)
NOPAT = 1.13b (EBIT 1.41b * (1 - 20.13%))
Current Ratio = 1.21 (Total Current Assets 25.29b / Total Current Liabilities 20.96b)
Debt / Equity = 0.55 (Debt 4.61b / totalStockholderEquity, last quarter 8.45b)
Debt / EBITDA = 1.19 (Net Debt 2.18b / EBITDA 1.83b)
Debt / FCF = 1.57 (Net Debt 2.18b / FCF TTM 1.39b)
Total Stockholder Equity = 8.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.57% (Net Income 827.7m / Total Assets 34.25b)
RoE = 9.94% (Net Income TTM 827.7m / Total Stockholder Equity 8.32b)
RoCE = 11.86% (EBIT 1.41b / Capital Employed (Equity 8.32b + L.T.Debt 3.59b))
RoIC = 8.93% (NOPAT 1.13b / Invested Capital 12.64b)
WACC = 8.10% (E(12.61b)/V(17.22b) * Re(10.54%) + D(4.61b)/V(17.22b) * Rd(1.79%) * (1-Tc(0.20)))
Discount Rate = 10.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.37%
[DCF] Terminal Value 73.90% ; FCFF base≈1.25b ; Y1≈998.3m ; Y5≈673.5m
[DCF] Fair Price = 124.5 (EV 12.22b - Net Debt 2.18b = Equity 10.04b / Shares 80.6m; r=8.10% [WACC]; 5y FCF grow -24.13% → 2.90% )
EPS Correlation: 43.51 | EPS CAGR: 6.45% | SUE: 0.57 | # QB: 0
Revenue Correlation: 14.27 | Revenue CAGR: 3.15% | SUE: 0.99 | # QB: 3
EPS next Quarter (2026-05-31): EPS=3.42 | Chg7d=+0.001 | Chg30d=+0.006 | Revisions Net=+2 | Analysts=11
EPS current Year (2026-11-30): EPS=14.62 | Chg7d=-0.014 | Chg30d=-0.023 | Revisions Net=-2 | Growth EPS=+10.8% | Growth Revenue=+3.9%
EPS next Year (2027-11-30): EPS=16.09 | Chg7d=-0.022 | Chg30d=-0.026 | Revisions Net=-2 | Growth EPS=+10.1% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.2% (Discount Rate 10.5% - Earnings Yield 6.4%)
[Growth] Growth Spread = +1.5% (Analyst 5.7% - Implied 4.2%)